NEJM - BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

NEJM - BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

https://www.nejm.org/doi/full/10.1056/NEJMoa2101765?query=featured_coronavirus

3 de março de 2021

Categorias

Categorias

Arquivo de Notícias